个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共10条记录   BILASTINE Histamine H-1 Receptor Antagonist Treatment of Allergic Rhinitis Treatment of Urticaria [作者：Ferrer, E; Pandian, R; Bolos, J; Castaner, R,期刊：Drugs of the Future, 页码：98-105 , 文章类型： Article，,卷期：2010年35-2] Bilastine is a potent histamine H-1 receptor antagonist currently preregistered for the oral treatment of allergic rhinitis and chronic idiopathic urticaria, and undergoing clinical investigation for the treatment of sea... ASTUPROTIMUT-R Therapeutic Cancer Vaccine [作者：Vasiliou, S,期刊：Drugs of the Future, 页码：89-92 , 文章类型： Article，,卷期：2010年35-2] The melanoma-associated antigen 3 (MAGE-3) is a commonly expressed tumor-specific antigen that represents a potential candidate for the development of cancer vaccines. Astuprotimut-R (GSK-249553), a vaccine comprising a ... BG-12 NF-kappa B Activation Inhibitor Treatment of Multiple Sclerosis [作者：Moharregh-Khiabani, D; Stangel, M,期刊：Drugs of the Future, 页码：93-97 , 文章类型： Article，,卷期：2010年35-2] BG-12 is an oral second-generation formulation of dimethyl fumarate (DMF), a fumaric acid ester (FAE). FAEs are licensed in some countries for the therapy of severe psoriasis. Due to their immunomodulatory effects, FAEs ... CURCUMIN: MULTIPLE MOLECULAR TARGETS MEDIATE MULTIPLE PHARMACOLOGICAL ACTIONS - A REVIEW [作者：Shehzad, A; Lee, YS,期刊：Drugs of the Future, 页码：113-119 , 文章类型： Review，,卷期：2010年35-2] Curcumin (diferuloylmethane), the active constituent of turmeric, has been used as a treatment for a wide variety of inflammatory conditions. Extensive research over the past two decades has shown that curcumin mediates ... THE MEDITERRANEAN DIET, PART IV: A DIET FOR OBESITY OR FOOD FOR FAT? [作者：Pauwels, EKJ; Kostkiewicz, M,期刊：Drugs of the Future, 页码：121-128 , 文章类型： Review，,卷期：2010年35-2] The rapidly increasing worldwide prevalence of obesity is currently considered a serious health problem that increases the risk for several comorbidities, such as diabetes, cardiovascular disease, hypertension, cancer, o... LINIFANIB Receptor Tyrosine Kinase Inhibitor Oncolytic [作者：Haddley, K,期刊：Drugs of the Future, 页码：106-112 , 文章类型： Article，,卷期：2010年35-2] Angiogenesis is the physiological process by which capillary growth occurs from an existing vascular network and ensures that tissues receive sufficient vascularization during organogenesis. It is well established that a... INTERLEUKIN-6 AS A TARGET IN CANCER [作者：Culig, Z,期刊：Drugs of the Future, 页码：135-141 , 文章类型： Article，,卷期：2010年35-2] Interleukin-6 (IL-6) is a multifunctional cytokine which is implicated in tumorigenesis and progression in several human cancers. Whereas in prostate cancer both growth-stimulatory and -inhibitory effects could be induce... 5(TH) DRUG DESIGN & LEAD DISCOVERY CONFERENCE 2009: LEAD FINDING STRATEGIES AND OPTIMIZATION CASE STUDIES [作者：Keseru, GM,期刊：Drugs of the Future, 页码：143-153 , 文章类型： Article，,卷期：2010年35-2] This review reports the most important contributions of the 5(th) Drug Design & Lead Discovery conference, held in October 2009 in San Diego. The conference was focused on lead-finding strategies and compound optimizatio... TREATMENTS FOR LEBER'S HEREDITARY OPTIC NEUROPATHY [作者：Rosenfeld, AE; Sadun, AA,期刊：Drugs of the Future, 页码：129-133 , 文章类型： Article，,卷期：2010年35-2] Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease characterized by devastating visual loss, usually in young adults. The typical presentation involves vision loss in one eye, due to a dense cen... NEW THERAPEUTIC APPROACHES IN EPILEPSY AND COMORBID DISORDERS HIGHLIGHTS OF THE 63(RD) ANNUAL MEETING OF THE AMERICAN EPILEPSY SOCIETY [作者：Dhir, A,期刊：Drugs of the Future, 页码：155-159 , 文章类型： Article，,卷期：2010年35-2] The 63(rd) Annual Meeting of the American Epilepsy Society was held in Boston, Massachusetts, USA on December 4-8, 2009. The meeting was attended by more than 4,000 delegates involved in both basic and clinical aspects o...